User:Fakeroute/be bold

During SARS Outbreak
As early as 2002.12.20., Guangzhou Institute of Respiratory Diseases, whose director was Zhong Nanshan, received the second-ever case of SARS patient. Over the next month, there were 28 more similar cases reported in Zhongshan alone. As a result, on 2003.1.21, Zhong, together with other doctors and researchers in related fields, reported this special disease at an emergency meeting and gave it the name Atypical pneumonia. This signified the beginning of the heroic fight against SARS.

On 2003.1.28, Zhong suddenly felt sick and realized that he had pneumonia after taking an X-ray. This was an extremely terrible news in the wake of SARS. As a result, Zhong decided not to take treatment in the hospital as that would create fear for the general public; instead, he went straight back home, hoping that it was just a regular pneumonia and that he could get over it successfully even at the age of 67. Luckily, it was not SARS. With the meticulous care from his wife, Li Shaofen, he managed to heal up after 8 days. After that, he immediately went back to Guangzhou Institute of Respiratory Diseases to direct the fight against SARS. On Feb. 11th, 2003, at the press conference held by the Guangdong Department of Health, Zhong explained the disease and its symptoms, as well as calming down the public by asserting that it is "preventable" and "curable".

Two of the most important contributions that Zhong Nanshan held for the ultimate victory over SARS are the following clinical practices. First, he used, for the first time while treating SARS patients Non-invasive ventilation method, which increased the amount of oxygen that the patients could intake, which helped to alleviate significantly the pain. Second and arguably more significant and difficult contribution was the use of Cortisone for the treating of patients under severe conditions. This treatment method significantly lowered the death rate of severe patients down to only 13% and decreased the total treatment time.

This second decision, however, was a politically controversial decision to make at the time. In February of 2003, Chinese Center for Disease Control and Prevention had already published authoritative view that normal Chlamydiae is the direct cause of the so-called Atypical pneumonia. As a result, the only legally prescribed way of treating SARS patients was to use Antibiotic s. Nevertheless, Zhong, basing his views on the observations of hundreds of patients here in Guangdong, was determined and strong enough to stand up against authority and developed his way of curing basing upon practical facts. With the support of Guangdong government and the proven results in Guangdong, his opinion was later taken as the standard protocol to treat SARS patients.

When delegates led by Dr. Evans from the World Health Organization visited China in early April, Zhong presented the characteristics of SARS as well as the treatment and prevention method in China. HIs presentation was received with great appraisal and the subject he presented was used widely for the fight against Severe acute respiratory syndrome all over the world.


 * Awards and Prizes
 * 2016：Guanghua Engineering Science and Technology Prize
 * National Award for Advances in Science and Technology, China (1997)
 * National Role Model of Labors (2005)
 * WAO Awards for Distinguished Recognition (2007)


 * Paper of the Year
 * The Lancet 2008: The editorial board praises "Zhong Nanshan and his team clarified that Carbocisteine ​​(Carbocisteine) can prevent the worsening of chronic obstructive pulmonary disease and can improve life at an affordable price, which is of great significance to developing countries. " (Note: The editorial board selected 6 papers for readers to vote, and finally announced two winners, one selected by the editorial board and one with the highest reader votes. Zhong's paper obtained the highest number of votes.)


 * Professional Titles
 * 1989：Fellow of the American College of Chest Physicians
 * 1993：Member of the European Respiratory Society
 * 2005：Fellow of the Royal College of Physicians of Ireland
 * 2011：Fellow of the Royal College of Physicians of Edinburgh
 * 201?：Fellow of the Royal College of Physicians of London


 * Honorary Degrees
 * 2005：Honorary Fellow of Hong Kong Academy of Medicine
 * 2008：Honorary Fellow of the European Respiratory Society
 * 2007：Doctor of Medicine (Honors), University of Edinburgh
 * 2011：Honorary Doctor of Science, University of Birmingham
 * 2013：Honorary Doctor of Science, The Chinese University of Hong Kong


 * Professional Societies
 * 1985-1990: Member, WHO Advisory Panel on Smoking & Health
 * 1982-1985: Member, Executive Committee, Chinese Medical Association
 * 1989-2000: Member, Executive Committee, American College of Chest Physician
 * 1989-present: Fellow, American College of Chest Physician (FCCP)